{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:37:38Z","timestamp":1784425058743,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-024-01502-0","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T12:01:48Z","timestamp":1729944108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of subsequent primary cancers in bladder cancer survivors"],"prefix":"10.1007","volume":"24","author":[{"given":"Yadong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"issue":"1","key":"1502_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"R Siegel","year":"2022","unstructured":"Siegel R, Miller K, Fuchs H, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1502_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277\u2013300.","journal-title":"CA Cancer J Clin"},{"issue":"7867","key":"1502_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","volume":"595","author":"T Powles","year":"2021","unstructured":"Powles T, Assaf Z, Davarpanah N, et al. ctDNA guiding adjuvant immunotherapy in urothelial carcinoma. Nature. 2021;595(7867):432\u20137.","journal-title":"Nature"},{"key":"1502_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3389\/fonc.2019.01315","volume":"9","author":"Y Guo","year":"2019","unstructured":"Guo Y, Jie X, Zhang A, et al. Evaluation of survival outcomes with Trimodal therapy as primary therapy for non-organ-confined bladder cancer. Front Oncol. 2019;9:1315.","journal-title":"Front Oncol"},{"issue":"10","key":"1502_CR5","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1007\/s00520-019-4649-z","volume":"27","author":"J Chung","year":"2019","unstructured":"Chung J, Kulkarni G, Morash R, et al. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory. Supportive Care Cancer\u202f: OffJ Multinatl Assoc Support Care Cancer. 2019;27(10):3877\u201385.","journal-title":"Supportive Care Cancer : OffJ Multinatl Assoc Support Care Cancer"},{"issue":"24","key":"1502_CR6","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2020.23130","volume":"324","author":"H Sung","year":"2020","unstructured":"Sung H, Hyun N, Leach C, Yabroff K, Jemal A. Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States. JAMA. 2020;324(24):2521\u201335.","journal-title":"JAMA"},{"issue":"1","key":"1502_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/cncr.29685","volume":"122","author":"J Lee","year":"2016","unstructured":"Lee J, DuBois S, Coccia P, Bleyer A, Olin R, Goldsby R. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer. 2016;122(1):116\u201323.","journal-title":"Cancer"},{"issue":"4","key":"1502_CR8","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.21873\/anticanres.11548","volume":"37","author":"A Khanal","year":"2017","unstructured":"Khanal A, Budhathoki N, Singh V, Shah B. Second primary malignancy in bladder carcinoma - a population-based study. Anticancer Res. 2017;37(4):2033\u20136.","journal-title":"Anticancer Res"},{"issue":"1","key":"1502_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/bju.13351","volume":"118","author":"J Muller","year":"2016","unstructured":"Muller J, Grosclaude P, Lap\u00f4tre-Ledoux B, et al. Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients. BJU Int. 2016;118(1):53\u20139.","journal-title":"BJU Int"},{"issue":"1","key":"1502_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12885-018-4530-3","volume":"18","author":"W Kwon","year":"2018","unstructured":"Kwon W, Joung J, Lim J, et al. Risk of second primary cancer among bladder Cancer patients: a population-based cohort study in Korea. BMC Cancer. 2018;18(1):617.","journal-title":"BMC Cancer"},{"issue":"2","key":"1502_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3816\/CGC.2004.n.016","volume":"3","author":"Y Kinoshita","year":"2004","unstructured":"Kinoshita Y, Singh A, Rovito P, Wang C, Haas G. Double primary cancers of the prostate and bladder: a literature review. Clin Prostate Cancer. 2004;3(2):83\u20136.","journal-title":"Clin Prostate Cancer"},{"issue":"1","key":"1502_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ijc.32101","volume":"145","author":"E Adjei Boakye","year":"2019","unstructured":"Adjei Boakye E, Buchanan P, Hinyard L, et al. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States. Int J Cancer. 2019;145(1):143\u201353.","journal-title":"Int J Cancer"},{"issue":"4","key":"1502_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1470-2045(18)30903-3","volume":"20","author":"C Bright","year":"2019","unstructured":"Bright C, Reulen R, Winter D, et al. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (teenage and young adult cancer survivor study): a population-based, cohort study. Lancet Oncol. 2019;20(4):531\u201345.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1502_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11764-018-0728-2","volume":"13","author":"M Gallaway","year":"2019","unstructured":"Gallaway M, Glover-Kudon R, Momin B, et al. Smoking cessation attitudes and practices among cancer survivors - United States, 2015. J Cancer Surviv\u202f: Res Pract. 2019;13(1):66\u201374.","journal-title":"J Cancer Surviv : Res Pract"},{"issue":"1","key":"1502_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1200\/JCO.2011.40.1919","volume":"30","author":"N Vogelzang","year":"2012","unstructured":"Vogelzang N, Benowitz S, Adams S, et al. Clinical cancer advances 2011: annual report on progress against cancer from the American society of clinical oncology. J Clin Oncol\u202f: Off J Am Soc Clin Oncol. 2012;30(1):88\u2013109.","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"issue":"2","key":"1502_CR16","first-page":"100","volume":"67","author":"R Smith","year":"2017","unstructured":"Smith R, Andrews K, Brooks D, et al. Cancer screening in the United States, 2017: a review of current American cancer society guidelines and current issues in cancer screening. CA: Cancer J clin. 2017;67(2):100\u201321.","journal-title":"CA: Cancer J clin"},{"issue":"1","key":"1502_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/pbc.23283","volume":"58","author":"S Knapke","year":"2012","unstructured":"Knapke S, Nagarajan R, Correll J, Kent D, Burns K. Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatr Blood Cancer. 2012;58(1):85\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"1502_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41568-020-00304-2","volume":"20","author":"A Dart","year":"2020","unstructured":"Dart A. Sexual dimorphism in cancer. Nat Rev Cancer. 2020;20(11):627.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1502_CR19","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41416-022-01718-5","volume":"126","author":"C Delon","year":"2022","unstructured":"Delon C, Brown KF, Payne NWS, Kotrotsios Y, Vernon S, Shelton J. Differences in cancer incidence by broad ethnic group in England, 2013\u20132017. Br J Cancer. 2022;126(12):1765\u201373. https:\/\/doi.org\/10.1038\/s41416-022-01718-5.","journal-title":"Br J Cancer"},{"issue":"11","key":"1502_CR20","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1001\/jamaoncol.2020.3697","volume":"6","author":"N Senft","year":"2020","unstructured":"Senft N, Hamel L, Manning M, et al. Willingness to discuss clinical trials among black vs white men with prostate cancer. JAMA Oncol. 2020;6(11):1773\u20137.","journal-title":"JAMA Oncol"},{"issue":"10","key":"1502_CR21","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1158\/1055-9965.EPI-11-0650","volume":"20","author":"K Yabroff","year":"2011","unstructured":"Yabroff K, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol, Biomarkers Prevention\u202f: Publ Am Assoc Cancer Res, Cosponsored Am Soc Preventive Oncol. 2011;20(10):2006\u201314.","journal-title":"Cancer Epidemiol, Biomarkers Prevention : Publ Am Assoc Cancer Res, Cosponsored Am Soc Preventive Oncol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01502-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01502-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01502-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:09:47Z","timestamp":1732986587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01502-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1502"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01502-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,26]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"As this is publicly available data, the study does not require consent for participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"247"}}